News

Deal Announcements

Spiration Breathes In New Venture Capital

Wednesday, March 26, 2008 5:37:00 AM PDT | VentureDeal staff
REDMOND, WA -- Medical device company Spiration Inc. announced the closing of its series G round, raising $18.5 million in new investment from a syndicate of existing investors.

Spiration is developing a number of medical devices aimed at treating lung disease and chronic obstructive pulmonary disease (COPD).

Versant Ventures led the round, which also included previous investors New Enterprise Associates, New Leaf Venture Partners, InterWest Partners, Investor Growth Capital and Three Arch Partners.

The company said it would use the proceeds to commercialize its IBV Valve System in Europe and continue the regulatory approval process in the U.S.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1